REGENERON PHARMACEUTICALS, INC. (REGN)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of
Q1 2024
Type / Class
Equity / COM
Shares, Excl. Options Q1 2024
$89.6 M
Holdings value Q1 2024
$86.2 B
Value change Q1 2024
+$1.13 B
Grand Portfolio weight change Q1 2024
+0.002%
Number of holders
1349
Number of Buys Q1 2024
581
Number of Sells Q1 2024
-531
Average Buys Q1 2024 %
+0.057%
Average Sells Q1 2024 %
-0.008%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 89.6 M $86.2 B +$1.13 B $962.49 1,257
2023 Q4 89.8 M $78.9 B +$747 M $878.29 1,235
2023 Q3 89.7 M $73.9 B -$573 M $822.96 1,152
2023 Q2 89.9 M $64.6 B -$2.75 B $718.54 1,138
2023 Q1 90.3 M $74.1 B -$1.22 B $821.67 1,160
2022 Q4 91.1 M $65.7 B -$201 M $721.49 1,121
2022 Q3 91.3 M $62.9 B -$160 M $688.87 1,045
2022 Q2 92.7 M $54.8 B +$596 M $591.13 1,028
2022 Q1 82.1 M $57.3 B +$1.53 B $698.42 1,063
2021 Q4 69.4 M $43.8 B +$442 M $631.52 1,046
2021 Q3 69.4 M $42 B +$478 M $605.18 990
2021 Q2 79.6 M $44.4 B -$28.9 M $558.54 948
2021 Q1 89.3 M $42.2 B -$353 M $473.14 901
2020 Q4 89.4 M $43.1 B -$836 M $483.11 876
2020 Q3 89.7 M $50.2 B -$627 M $559.78 888
2020 Q2 90.6 M $56.5 B +$10.7 B $623.65 917
2020 Q1 73.7 M $36 B +$992 M $488.29 786
2019 Q4 73.1 M $27.4 B +$184 M $375.48 676
2019 Q3 72.7 M $20.2 B -$57 M $277.40 602
2019 Q2 73.4 M $23 B +$181 M $313.00 641
2019 Q1 72.3 M $29.7 B -$48.4 M $410.62 691
2018 Q4 72.8 M $27.2 B -$163 M $373.50 650
2018 Q3 73 M $29.5 B +$479 M $404.04 629
2018 Q2 71.9 M $24.8 B +$363 M $344.99 606
2018 Q1 72 M $24.8 B +$207 M $344.36 606
2017 Q4 71.1 M $26.7 B -$476 M $375.96 620
2017 Q3 71.9 M $32.1 B -$384 M $447.12 593
2017 Q2 72.6 M $35.7 B +$1.28 B $491.14 589
2017 Q1 71.4 M $27.7 B +$2.46 B $387.51 563
2016 Q4 71.7 M $26.3 B -$645 M $367.09 567
2016 Q3 72.7 M $29.2 B +$506 M $402.02 544
2016 Q2 71.6 M $25 B -$370 M $349.23 530
2016 Q1 71.6 M $25.8 B -$143 M $360.44 532
2015 Q4 72.8 M $39.5 B -$22.6 M $542.87 566
2015 Q3 73 M $34 B -$197 M $465.14 550
2015 Q2 72.8 M $37.1 B +$405 M $510.13 534
2015 Q1 73 M $32.9 B +$441 M $451.48 508
2014 Q4 72 M $29.6 B +$118 M $410.25 509
2014 Q3 71.6 M $25.8 B -$605 M $360.52 475
2014 Q2 73.4 M $20.7 B -$13.5 M $282.47 448
2014 Q1 73.4 M $22 B -$741 M $300.28 450